loadpatents
name:-1.4623548984528
name:-0.085325002670288
name:-0.062168121337891
Hay; Bruce A. Patent Filings

Hay; Bruce A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hay; Bruce A..The latest application filed is for "formulated and/or co-furmulated liposome compositions containing toll-like receptor ("tlr") agonist prodrugs useful in the treatment of cancer and methods thereof".

Company Profile
5.10.26
  • Hay; Bruce A. - Niskayuna NY
  • Hay; Bruce A - Niskayuna NY
  • Hay; Bruce A. - Encino CA
  • Hay; Bruce A - Encino CA
  • Hay; Bruce A. - Pasadena CA
  • Hay; Bruce A - Pasadena CA
  • Hay; Bruce A. - Niskayuan NY
  • Hay; Bruce A. - Los Angeles CA
  • Hay, Bruce A. - East Lyme CT
  • Hay; Bruce A. - Groton CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Formulated and/or co-furmulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof
App 20220193187 - Stover; David ;   et al.
2022-06-23
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
App 20220080051 - Stover; David ;   et al.
2022-03-17
Composition of scalable thyrointegrin antagonists with improved retention in tumors
Grant 11,186,551 - Mousa , et al. November 30, 2
2021-11-30
Composition Of Scalable Thyrointegrin Antagonists With Improved Retention In Tumors
App 20210340111 - Mousa; Shaker A. ;   et al.
2021-11-04
Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof
App 20210260197 - Stover; David ;   et al.
2021-08-26
Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof
App 20210187066 - Stover; David ;   et al.
2021-06-24
Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof
App 20210163418 - Stover; David ;   et al.
2021-06-03
Population control using engineered translocations
Grant 10,966,414 - Hay , et al. April 6, 2
2021-04-06
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
Grant 10,961,204 - Mousa , et al. March 30, 2
2021-03-30
Population Control Using Engineered Translocations
App 20200404892 - Hay; Bruce A ;   et al.
2020-12-31
Population control using engineered translocations
Grant 10,791,722 - Hay , et al. October 6, 2
2020-10-06
Dna Sequence Modification-based Gene Drive
App 20200140885 - Hay; Bruce A. ;   et al.
2020-05-07
Antibody-mediated immunocontraception
Grant 10,570,200 - Hay , et al. Feb
2020-02-25
Dna Sequence Modification-based Gene Drive
App 20180320164 - Hay; Bruce A ;   et al.
2018-11-08
Population Control Using Engineered Translocations
App 20160345556 - Hay; Bruce A. ;   et al.
2016-12-01
Induction Of Antigen-specific Tolerance
App 20160060358 - Hay; Bruce A.
2016-03-03
Regulation Of Insect Populations
App 20150237838 - HAY; BRUCE A. ;   et al.
2015-08-27
Repressible Lethal System For Regulating Insect Populations
App 20140283155 - Akbari; Omar S. ;   et al.
2014-09-18
Antibody-mediated Immunocontraception
App 20140223591 - Hay; Bruce A. ;   et al.
2014-08-07
Pyrimidone Compounds As GSK-3 Inhibitors
App 20100292205 - Lefker; Bruce A. ;   et al.
2010-11-18
Detection of protein expression in vivo using fluorescent puromycin conjugates
App 20060057069 - Starck-Green; Shelley R. ;   et al.
2006-03-16
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
App 20050054581 - Hay, Bruce A. ;   et al.
2005-03-10
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
App 20040157834 - Hay, Bruce A. ;   et al.
2004-08-12
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
Grant 6,720,330 - Hay , et al. April 13, 2
2004-04-13
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
App 20040058877 - Hay, Bruce A. ;   et al.
2004-03-25
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
Grant 6,696,418 - Hay , et al. February 24, 2
2004-02-24
Process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon
App 20030125528 - Hay, Bruce A. ;   et al.
2003-07-03
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
Grant 6,495,589 - Hay , et al. December 17, 2
2002-12-17
Method For Identifying Proteases, Protease Target Sites And Regulators Of Protease Activity In Cells
App 20020132327 - HAY, BRUCE A. ;   et al.
2002-09-19
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
App 20020128206 - Hay, Bruce A. ;   et al.
2002-09-12
Somatostatin antagonists and agonists
App 20020091090 - Cole, Bridget M. ;   et al.
2002-07-11
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
App 20020091125 - Hay, Bruce A. ;   et al.
2002-07-11
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
App 20020016298 - Hay, Bruce A. ;   et al.
2002-02-07
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
App 20010047030 - Hay, Bruce A. ;   et al.
2001-11-29
Steam stripping of odor forming impurities from hop flavors
Grant 5,013,572 - Hay May 7, 1
1991-05-07
Methods for making tetrahydroisoalpha and hexahydroisoalpha acids
Grant 5,013,571 - Hay May 7, 1
1991-05-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed